FIZE Medical

Patient Monitoring Platform

Health Tech & Life Sciences
Active
Series A Modi'in Makabim-Re'ut Founded 2020
Total raised
$45.9M
Last: Series A 2026-03
Stage
Series A
Founded
2020
Headcount
48
HQ
Modi'in Makabim-Re'ut
Sector
Health Tech & Life Sciences

About

FIZE Medical provides the first platform technology to remotely monitor and manage patients with an indwelling Foley catheter. The company developed and manufactures FIZE kUO device which enables digital real-time measurement of kidney urine output and key indicators of the health status of patients found in their urine with customizes alerts, allowing evidence based clinical decision-making .

The Company’s device has been FDA registered and have been tested in clinical trials for efficacy and safety.

Funding history · 6 rounds · $45.9M total

2026-03
Series A $6.0M
2025-11
Undisclosed Undisclosed
2024-12
Series A $14.0M
2022-08
Series A $15.2M
2021-12
Series A $4.5M
2021-04
Series A $5.2M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is FIZE Medical's core product?
FIZE Medical provides a platform technology to remotely monitor and manage patients with an indwelling Foley catheter. Their device, FIZE kUO, enables digital real-time measurement of kidney urine output and other health indicators, with customized alerts for clinical decision-making.
When was FIZE Medical founded?
FIZE Medical was founded in April 2020.
What is the total amount of funding FIZE Medical has raised to date?
FIZE Medical has raised a total of $45,870,000 USD in funding.
Which investors participated in FIZE Medical's Series A funding rounds?
Key investors in FIZE Medical's Series A rounds include Rapha Capital Management, Mendham Investment Group, White Hibiscus Capital, Valitas Ventures, and eHealth Ventures. For a full financing history, please refer to startupim.
Has FIZE Medical's device received regulatory approval?
Yes, FIZE Medical's device has been FDA registered and tested in clinical trials for efficacy and safety.
What was a significant funding event for FIZE Medical in March 2026?
In March 2026, FIZE Medical announced a $6 million warrant exercise, bringing their total Series A financing to $36 million.
What distribution agreement did FIZE Medical announce in December 2025?
In December 2025, FIZE Medical announced an exclusive distribution agreement with Asahi Kasei Medical for the launch of the FIZE kUO system in Japan.
What strategic partnership did FIZE Medical secure in November 2025?
In November 2025, FIZE Medical secured an investment and expanded its Israeli distribution through Eldan, a Neopharm Group company.
Did FIZE Medical receive any grants?
Yes, in February 2024, FIZE Medical received a $1,000,000 grant from the IIA.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote Monitoring
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicesurologynephrologydigital-healthcaresoftware-applicationsdoctorsclinical-datadata-analyticsmonitoringautomationreal-timehospitalsremote-monitoringvital-signs